掃碼下載
BTC $76,960.67 -2.09%
ETH $2,289.78 -3.25%
BNB $625.98 -1.30%
XRP $1.39 -2.19%
SOL $84.17 -2.75%
TRX $0.3240 +0.13%
DOGE $0.0998 +0.57%
ADA $0.2478 -1.61%
BCH $448.41 -1.21%
LINK $9.27 -2.13%
HYPE $41.29 -3.66%
AAVE $97.68 +0.13%
SUI $0.9331 -1.97%
XLM $0.1650 -3.68%
ZEC $340.65 -4.69%
BTC $76,960.67 -2.09%
ETH $2,289.78 -3.25%
BNB $625.98 -1.30%
XRP $1.39 -2.19%
SOL $84.17 -2.75%
TRX $0.3240 +0.13%
DOGE $0.0998 +0.57%
ADA $0.2478 -1.61%
BCH $448.41 -1.21%
LINK $9.27 -2.13%
HYPE $41.29 -3.66%
AAVE $97.68 +0.13%
SUI $0.9331 -1.97%
XLM $0.1650 -3.68%
ZEC $340.65 -4.69%

彭博社:Arthur Hayes 近期重金投資某人類壽命延長公司,過去 1 年定期接受幹細胞靜脈輸注治療

2025-08-21 09:43:07
收藏

ChainCatcher 消息,据彭博社報導,BitMEX 聯合創始人 Arthur Hayes 正將投資目光轉向人類壽命延長領域,其近期重金投資了一家在墨西哥和曼谷設有診所的幹細胞企業,並加入其董事會。

過去一年他定期乘機前往接受靜脈輸注治療,直言"希望儘可能健康地延長壽命"。儘管因品牌重塑暫未透露公司名稱,但他強調:這是未來趨勢------越來越多國家正放寬幹細胞使用法規。

app_icon
ChainCatcher 與創新者共建Web3世界